Metastatic Small Intestinal Adenocarcinoma
4 clinical trials · Condition
◉ Watch Metastatic Small Intestinal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders (NCT04729322) | M.D. Anderson Cancer Center | 2021-02-22 |
| Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers (NCT04205968) | SWOG Cancer Research Network | 2020-06-01 |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
| Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT02949219) | Academic and Community Cancer Research United | 2017-03-24 |
Track Metastatic Small Intestinal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.